CNIPA.AI
Back to Search
Dossier

MATN1-AS1在制备治疗子宫内膜癌的药物中的应用

InventionActive
8Claims · 1 independent
§ Ⅰ

Dossier Overview

IPC Classification

A61K 31/7105 (2006.01)A61P 35/00 (2006.01)A61P 15/00 (2006.01)

本发明提供了一种MATN1‑AS1在制备治疗子宫内膜癌的药物中的应用,MATN1‑AS1通过调控miR‑200b的表达来调节子宫内膜癌细胞的增殖。本发明验证了MATN1‑AS1通过E2F1/miR‑200b信号轴促进子宫内膜癌的生长,阐明了MATN1‑AS1促进子宫内膜癌发展的调控机制,为子宫内膜癌的发病机制提供新的理论依据,并为子宫内膜癌的治疗提供新的潜在作用靶点。

Sign in to read the full text

Claim 1 is shown. Create a free account to read all 8 claims, the full description, all drawings, translations and legal status.

  • All claims
  • Technical field
  • Background
  • Summary
  • Drawing descriptions
  • Detailed description

External Resources